Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer Based on Human Papillomavirus (HPV) Detection, Quantification, Genotyping and DNA Methylation in Self-samples (COMBISCREEN)

NCT06598176 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT06598176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06598176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Combined Molecular Screening and Triage Test for Cervical Cancer Based on Human Papillomavirus (HPV) Detection, Quantification, Genotyping and DNA Methylation in Self-samples (COMBISCREEN)
Lead sponsor
Universiteit Antwerpen
Phase
Not applicable
Overall status
Recruiting
Start date
March 28, 2024
Completion date
February 28, 2037
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv-related cervical carcinoma, human papilloma virus, uterine cervical dysplasia, uterine cervical neoplasm